News and Trends 5 Dec 2022
New company Liminatus Pharma Inc to develop three cancer treatments
Clinical-stage biopharma company Liminatus Pharma LLC and Iris Acquisition Corp, a publicly traded special purpose acquisition company formed for the purpose of acquiring or merging with one or more businesses,…